EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Triple rAAV9 Vector Combinations Encoding Broadly Neutralizing Antibodies Effectively Suppress HIV-1 Infection in Humanized Mice

Danila S Leontyev, Felix A Urusov iD, Dina V Glazkova, Boris V Belugin iD, Anastasia A Mitiushina, Galina M Tsyganova iD, Sergey M Yudin iD, Elena V Bogoslovskaya iD, German A Shipulin

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262211051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Danila S Leontyev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency, 119992 Moscow, Russia. Hauptthemen laut MEDLINE: HIV-1, Dependovirus, HIV Infections, Genetic Vectors. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the protective efficacy of two distinct combinations of three recombinant adeno-associated virus serotype 9 (rAAV9) vectors encoding broadly neutralizing antibodies against HIV-1—CombiMab-1 and CombiMab-2—in mice humanized with primary CD4+ T-lymphocytes. We demonstrated that mice preventively treated with CombiMab-1 or CombiMab-2 did not develop viremia and maintained human CD4+ T-lymphocyte counts following viral challenge, in contrast to control animals. These results demonstrate the significant protective capacity of CombiMab-1 and CombiMab-2 against HIV-1 challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1DependovirusHIV InfectionsGenetic VectorsAntibodies, NeutralizingBroadly Neutralizing AntibodiesAnimalsMiceHumansCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

10-107410E8AAV vectorsCD4+ T-lymphocytesCombiMab-1CombiMab-2HIV-1N6PGDM1400VRC07-523broadly neutralizing antibodieshumanized micepassive immunizationviral load

Substanzen

Antibodies, NeutralizingBroadly Neutralizing Antibodies

Autor:innen und Institutionen

  • Centre for Strategic Planning and Management of Biomedical Health Risks, Federal Medical Biological Agency, 119992 Moscow, Russia.

ORCID-Profile: Felix A Urusov, Boris V Belugin, Galina M Tsyganova, Sergey M Yudin, Elena V Bogoslovskaya

Zitieren

APA

Leontyev, D. S., Urusov, F. A., Glazkova, D. V., Belugin, B. V., Mitiushina, A. A., Tsyganova, G. M., Yudin, S. M., Bogoslovskaya, E. V., & Shipulin, G. A. (2025). Triple rAAV9 Vector Combinations Encoding Broadly Neutralizing Antibodies Effectively Suppress HIV-1 Infection in Humanized Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211051

Vancouver

Leontyev DS, Urusov FA, Glazkova DV, Belugin BV, Mitiushina AA, Tsyganova GM, et al. Triple rAAV9 Vector Combinations Encoding Broadly Neutralizing Antibodies Effectively Suppress HIV-1 Infection in Humanized Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211051

BibTeX
@article{Leontyev2025,
  author = {Leontyev, Danila S and Urusov, Felix A and Glazkova, Dina V and Belugin, Boris V and Mitiushina, Anastasia A and Tsyganova, Galina M and Yudin, Sergey M and Bogoslovskaya, Elena V and Shipulin, German A},
  title = {Triple rAAV9 Vector Combinations Encoding Broadly Neutralizing Antibodies Effectively Suppress HIV-1 Infection in Humanized Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262211051}
}
Kostenlos starten →